Enadoline and Butorphanol: Evaluation of κ-Agonists on Cocaine Pharmacodynamics and Cocaine Self-Administration in Humans
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Preclinical studies have demonstrated that κ-opioid agonists can attenuate the neurochemical and behavioral effects of cocaine that are related to its reinforcing efficacy, suggesting that κ-agonists may serve as pharmacotherapies for cocaine dependence. This 8-week inpatient study examined the ability of enadoline, a selective and high-efficacy κ-agonist, and butorphanol, a mixed agonist with intermediate efficacy at both μ- and κ-receptors, to reduce the direct pharmacodynamic effects and self-administration of intravenous cocaine in humans ( n = 8). Acute doses of intramuscular enadoline (20, 40, and 80 μg/kg), butorphanol (1.5, 3, and 6 mg/70 kg) and placebo were examined separately as pretreatments during each of three test sessions with cocaine in a constrained random order. A cocaine dose-effect session (0, 20, and 40 mg cocaine i.v., 1 h apart) examined direct pharmacodynamic interactions on subjective and physiological indices; self-administration sessions examined choice behavior for cocaine (40 mg i.v. for six trials) versus money 1) in the presence of a sample cocaine dose with money choices presented in ascending value, and 2) in the absence of a sample dose with money choices presented in descending values. Enadoline (80 μg/70 kg) significantly ( p < 0.05) reduced some of the positive subjective effects of cocaine (e.g., ratings of “high”), while butorphanol failed to modify subjective responses. Both agents were safely tolerated in combination with cocaine without adverse physiological responses. Cocaine self-administration was significantly greater across all pretreatment conditions when the sample dose was given and ascending money choices were used. Enadoline and butorphanol failed to modify cocaine self-administration. These data suggest that these κ-agonists may be safely administered in the presence of cocaine but do not produce significant attenuation of cocaine's direct effects or self-administration under these acute dosing conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans
Walsh, S., Strain, E., Abreu, M., & Bigelow, G. (2001) · Psychopharmacology · doi:10.1007/s002130100788 · Cited by 258 · cited 3×
“Butorphanol, thought to act as both a partial - and partial -agonist (Leander, 1983; Dykstra, 1990; Vivian et al., 1999), produces an acute subjective effects profile comprised of both prototypic - and -opioid effects (Jasinski et al., 1976; Preston and Bigelow, 1994; Walsh et al., 2001).”
Self-citationCocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
Sivam, S. P. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22808-7 · Cited by 167
Cited by
The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse
Wee, S., & Koob, G. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1825-8 · Cited by 398
Controversies in translational research: drug self-administration.
Haney, M., & Spealman, R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1079-x · Cited by 270
“, monetary reinforcers worth four times more than the street value of the dose of cocaine (Walsh et al. 2001; Donny et al. 2003, 2004).”
BackgroundInfluentialMueller, E. T., Landes, R. D., Kowal, B. P., Yi, R., Stitzer, M. L., Burnett, C. A., & Bickel, W. K. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283305ec7 · Cited by 54
“Walsh et al. (2001) and Donny et al. (2004) used money amounts that decreased across a series of discrete trials, which posed to their participants the choice between cocaine administration and receiving money rewards.”
Background
Metadata
- Authors
- Walsh, S. L., Geter-Douglas, B., Strain, E. C., & Bigelow, G. E.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2001-10
- Volume
- 299
- Issue
- 1
- Pages
- 147-158
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W4406054958
- Cited by
- 68
- References
- 3
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enadoline and Butorphanol: Evaluation of κ-Agonists on Cocaine Pharmacodynamics and Cocaine Self-Administration in Humans. https://app.cochat.ai/papers/10.1016/s0022-3565(24)29312-5
- The paper
- Walsh, S. L., Geter-Douglas, B., Strain, E. C., & Bigelow, G. E. (2001). Enadoline and Butorphanol: Evaluation of κ-Agonists on Cocaine Pharmacodynamics and Cocaine Self-Administration in Humans. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(24)29312-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.